RT @drjamesboyle: #ICYMI our #review in this @DiabetologiaJnl special issue: A new perspective on #metformin therapy in #T1D @johnrpetrie @…
#ICYMI our #review in this @DiabetologiaJnl special issue: A new perspective on #metformin therapy in #T1D @johnrpetrie @UofGMedicine @UofGICAMS #REMOVAL https://t.co/rC9aJDiE67
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. A new perspective…
RT @AyalaGise: Metformina y #diabetes tipo 1. Interesante! @fmdiabetes @DrTiroides @dulcesitosmios @elgringoinspain @antillonendop @BeyondT…
RT @NHSResearchScot: 'a new perspective on metformin therapy in type 1 diabetes and suggests a potential role for reducing the long-term ri…
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. A new perspective…
RT @AyalaGise: Metformina y #diabetes tipo 1. Interesante! @fmdiabetes @DrTiroides @dulcesitosmios @elgringoinspain @antillonendop @BeyondT…
RT @AyalaGise: Metformina y #diabetes tipo 1. Interesante! @fmdiabetes @DrTiroides @dulcesitosmios @elgringoinspain @antillonendop @BeyondT…
RT @drjamesboyle: Incase you missed our review of adjunctive #metformin therapy in #T1DM @DiabetologiaJnl: charts history from the late Har…
A new perspective on metformin therapy in type 1 diabetes https://t.co/q48rM4dvae #diabetes
RT @AyalaGise: Metformina y #diabetes tipo 1. Interesante! @fmdiabetes @DrTiroides @dulcesitosmios @elgringoinspain @antillonendop @BeyondT…
Metformina y #diabetes tipo 1. Interesante! @fmdiabetes @DrTiroides @dulcesitosmios @elgringoinspain @antillonendop @BeyondType1 @DrEnriqueGH @spin1371 @drsoberon @drferramez @profesoreruben
RT @drjamesboyle: Incase you missed our review of adjunctive #metformin therapy in #T1DM @DiabetologiaJnl: charts history from the late Har…
'a new perspective on metformin therapy in type 1 diabetes and suggests a potential role for reducing the long-term risk of cardiovascular disease' Read more:https://t.co/JTBB0anph2 #diabetes #research #REMOVAL study @NRSDiabetes
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. A new perspective…
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. A new perspective…
Incase you missed our review of adjunctive #metformin therapy in #T1DM @DiabetologiaJnl: charts history from the late Harry Keen's trial to @johnrpetrie #REMOVAL trial data suggesting wider off-label use to improve CVD risk management in #T1DM @UofGMVLS @N
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. A new perspective…
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. A new perspective…
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. A new perspective…
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. A new perspective…
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. A new perspective…
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. A new perspective…
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. A new perspective…
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. A new perspective…
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. A new perspective…
RT @DiabetologiaJnl: Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. A new perspective…
Saving this for tomorrow @matthewgriggst2
This collection is so much valuable.
Edición especial sobre la Metformina
Diabetologia's special issue on metformin - read the collection for free at https://t.co/WLXS40Gegz. A new perspective on metformin therapy in type 1 diabetes by Livingstone, Boyle, Petrie https://t.co/Xip5pleex4 #T1D #metformin #cholesterol #atheroscleros
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pleex4 #metformin #diabetes #T1D #EASD2017
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pleex4 #metformin #diabetes #T1D #EASD2017
A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pleex4 #metformin #diabetes #T1D #EASD2017
RT @johnrpetrie: 60 years of metformin and we're still learning #EASD2017 #springerlink https://t.co/axjrdtAWTy
RT @johnrpetrie: 60 years of metformin and we're still learning #EASD2017 #springerlink https://t.co/axjrdtAWTy
RT @johnrpetrie: 60 years of metformin and we're still learning #EASD2017 #springerlink https://t.co/axjrdtAWTy
RT @johnrpetrie: 60 years of metformin and we're still learning #EASD2017 #springerlink https://t.co/axjrdtAWTy
RT @johnrpetrie: 60 years of metformin and we're still learning #EASD2017 #springerlink https://t.co/axjrdtAWTy
A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pkWD8u
RT @johnrpetrie: 60 years of metformin and we're still learning #EASD2017 #springerlink https://t.co/axjrdtAWTy
@Jdrfuk supporters, you made the REMOVAL study happen, adding new knowledge on how to live longer healthier lives with #T1D. Thank you. https://t.co/DCn8vUgaRD
60 years of metformin and we're still learning #EASD2017 #springerlink https://t.co/axjrdtAWTy
RT @profsmarshall: Upfront & free to read in Sept @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/…
RT @profsmarshall: Upfront & free to read in Sept @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/…
RT @M_Muneer: REMOVAL trial suggests MFN in T1 can address atherosclerosis, weight and LDL. https://t.co/j3LEAw020V
REMOVAL trial suggests MFN in T1 can address atherosclerosis, weight and LDL. https://t.co/j3LEAw020V
Upfront & free to read in Sept @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Vp3NcncwkN
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pleex4
RT @annav_ciardullo: Nuova vita alla metformina nel diabete tipo 1: riduce peso, migliora ip compenso e l'ispessimento carotideo mediointim…
Nuova vita alla metformina nel diabete tipo 1: riduce peso, migliora ip compenso e l'ispessimento carotideo mediointimale https://t.co/BY7TGBPeJm
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pleex4
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pleex4
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pleex4
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pleex4
A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pleex4
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pkWD8u
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pkWD8u
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pkWD8u
RT @sball_endo: A new perspective on metformin therapy in type 1 diabetes | SpringerLink https://t.co/9y2PAi9XNH
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pkWD8u
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pkWD8u
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pkWD8u
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pkWD8u
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pkWD8u
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pkWD8u
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pkWD8u
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pkWD8u
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pkWD8u
RT @sball_endo: A new perspective on metformin therapy in type 1 diabetes | SpringerLink https://t.co/9y2PAi9XNH
A new perspective on metformin therapy in type 1 diabetes | SpringerLink https://t.co/9y2PAi9XNH
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pkWD8u
RT @DiabetologiaJnl: A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pkWD8u
A new perspective on metformin therapy in type 1 diabetes https://t.co/Xip5pkWD8u
A new perspective on metformin therapy in type 1 diabetes https://t.co/4Y3xACdni6
A new perspective on metformin therapy in type 1 diabetes https://t.co/ogzFNKoakI via @instapaper